代表性论著、科研获奖、人才称号 |
近5年代表性论著 1. Li Y, Liu C, Yang L, He L, Li M, Gou G, Feng D, Zhang X, Wang F, Fu J, Dang S. Add-on PD-1 inhibitor with Peg-IFNα therapy favors functional cure of chronic hepatitis B patients. J Transl Int Med. 2026 Feb 13;14(1):123-133. (Q1 IF 12.5) 2. Wang M#, Zhang M#, Deng H, Zhang Y, Liu C, Chen Y, Zhang C, Zhang W, Jia X, Dang S, Li Y*. Integrative scRNA-seq and transcriptomic analysis initially reveals monocyte/macrophage activation drives EV-A71-induced immune dysregulation and neural injury in severe HFMD. Front Immunol. 2025 Aug, 21;16:1620633. (Q1 IF 7.0) 3. Li Y, Li JiaXin, Li Ting, Deng Huiling. Plasma nontargeted metabolomics study of H1N1 and H3N2 influenza in children, Frontiers in Cellular and Infection Microbiology,2025.2 (Q1 IF 5.5) 4. Yaping Li#, Ting Li#, Min Liu, XinYu Wang, Song Zhai, Ruihong Qin, Chenrui Liu, Yuanyi Chen,Meng Zhang, Xiaoli Jia*. Metabolomic and Clinical Feature Analyses of Plasma from Influenza A Patients. Scientific Reports. 2025 Nov 28;15(1):42616. (Q1 IF 4.9) 5. Li Y, Lin Y, Gou G, Cui D, Gao X, Xu G, Zu H, Dang S. Effectiveness and Safety of Tenofovir Amibufenamide in the Treatment of Chronic Hepatitis B: A Real-world, Multicenter Study. J Clin Transl Hepatol. 2025 Mar 28;13(3):207-215. (Q1 IF 6.0) 6. Li M, Li YP*, Deng HL, Wang MQ, Chen Y, Zhang YF, Wang J, Dang SS. DNA Methylation and SNP in IFITM3 are correlated with patients with hand, foot and mouth disease caused by enterovirus 71. Int J Infect Dis. 2021,105:199-208. (IF 12.074, Q1,通讯) 科研获奖: 1.李亚萍(2/7);手足口病重症化发病机制及综合防治策略应用,陕西省科技厅,科技进步,省部二等奖,2022(党双锁;李亚萍;李梅;高宁;王文俊;吴媛;丁石梅;贾晓黎;翟嵩)。 2. 李亚萍(4/7);重症手足口病早期诊断关键技术研发平台建设与应用,陕西省科技厅,科技进步,省部二等奖,2024(邓慧玲;王洪亮;张玉凤;李亚萍;杜嘉仪;万涵;陈媛;王小燕;付建军;谢燕)。 3. 李亚萍(2/7);手足口病发病机制及综合防治研究,陕西省教育厅,陕西高等学校科学技术奖,二等奖,2021(党双锁;李亚萍;李梅;高宁;王文俊;贾晓黎;翟嵩)。 |